On 12 May 2026, at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye, groundbreaking findings from the Phase…
Read More

On 12 May 2026, at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye, groundbreaking findings from the Phase…
Read More
A recent population-based study, published in CANCER, a journal of the American Cancer Society, has issued a significant alert to…
Read More
Scientists at the forefront of regenerative medicine, based at the esteemed Karolinska Institutet and KTH Royal Institute of Technology in…
Read More
Cellular Intelligence, a burgeoning biotech startup, has announced the acquisition of global rights to a clinical-stage Parkinson’s disease cell therapy,…
Read More
Seven months after Danish pharmaceutical giant Novo Nordisk officially shuttered its dedicated cell therapy unit in October 2025, a significant…
Read More
A collaborative international study led by researchers at Ludwig Cancer Research has identified a breakthrough therapeutic strategy for acute myelogenous…
Read More
Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…
Read More
In a significant move to bolster its pipeline and solidify its strategic focus on the complex challenges of obesity, global…
Read More
A recent population-based study, published in CANCER, a prestigious journal of the American Cancer Society, has brought to light a…
Read More
Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…
Read More